Voglio sapere a riguardo di…

sradovich on DSKJLST7X2PROD with NOTICES

Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices data. You may submit comments on any topic related to this activity. Comments received, including attachments and other supporting materials, are part of the public record and subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display.
CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/
near duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket.
CDC does not accept comment by email.
Oral Public Comment: The public is welcome to participate, via Zoom, during the public comment periods on September 28, 2021, from 11:30 a.m. to 12:00 p.m., EDT, and on September 29, 2021, from 12:10 p.m. to 12:40 p.m., EDT. Please note that the public comment periods end at the times indicated above. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first come-first served basis.
Members of the public who wish to address the WTCHP STAC during the oral public comment sessions must sign up by providing their name and desired date for commenting to Mia Wallace, Committee Management Specialist, via email: MWallace@cdc.gov, or the addresses section provided in this notice by September 21, 2021.
Written Public Comment: Written comments will also be accepted from those unable to attend the public session per the instructions provided in the addresses section above. Written comments received in advance of the meeting will be included in the official record of the meeting. Written comments received by September 21, 2021 will be provided to the STAC prior to the meeting. The docket will close on September 29, 2021.
Policy on Redaction of Committee Meeting Transcripts Public Comment:
Transcripts will be prepared and posted to http www.regulations.gov within 60
days after the meeting. If a person making a comment gives their name, no attempt will be made to redact that name. NIOSH will take reasonable steps to ensure that individuals making public comments are aware that their comments including their name, if
VerDate Sep<11>2014

00:30 Sep 04, 2021

Jkt 253001

provided will appear in a transcript of the meeting posted on a public website.
Such reasonable steps include a statement read at the start of the meeting stating that transcripts will be posted, and names of speakers will not be redacted. If individuals in making a statement reveal personal information e.g., medical information about themselves, that information will not usually be redacted. The CDC Freedom of Information Act coordinator will, however, review such revelations in accordance with the Freedom of Information Act and, if deemed appropriate, will redact such information. Disclosures of information concerning third party medical information will be redacted.
The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202119224 Filed 9321; 8:45 am BILLING CODE 416318P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Solicitation of Nominations for Membership on the Lead Exposure and Prevention Advisory Committee LEPAC
Centers for Disease Control and Prevention CDC, Department of Health and Human Services HHS.
ACTION: Notice.
AGENCY:

The Centers for Disease Control and Prevention CDC is soliciting nominations for membership on the LEPAC. The LEPAC is composed of 15 members that are Federal and nonFederal experts in fields associated with lead screening, the prevention of lead exposure, and services for individuals and communities affected by lead exposure. Nominations are being sought for individuals with expertise in the fields of epidemiology, toxicology, mental health, pediatrics, early childhood education, special education, diet and nutrition, and environmental
SUMMARY:

PO 00000

Frm 00118

Fmt 4703

Sfmt 4703

U:07SEN1.SGM

50129

health. Members may be invited to serve for three-year terms. Selection of members is based on candidates qualifications to contribute to the accomplishment of LEPAC objectives.
DATES: Nominations for membership on the LEPAC must be received no later than November 1, 2021. Packages received after this time will not be considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to LEPAC@cdc.gov.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H., Designated Federal Officer, National Center for Environmental Health, CDC, 4770
Buford Highway NE, Atlanta, GA
303294018, Telephone: 770 488
6774, PAllwood@cdc.gov.
SUPPLEMENTARY INFORMATION: The members of this committee are selected by the Secretary of the U.S. Department of Health and Human Services HHS.
The committees objective is to advise the Secretary, HHS and the Director, Centers for Disease Control and Prevention/Administrator, Agency for Toxic Substances and Disease Registry on a range of activities to include: 1
Review of Federal programs and services available to individuals and communities exposed to lead; 2 review of the current research on lead exposure to identify additional research needs;3
review of and identification of best practices, or the need for best practices regarding lead screening and the prevention of lead exposure; 4
identification of effective services, including services relating to healthcare, education, and nutrition for individuals and communities affected by lead exposure and lead poisoning, including in consultation with, as appropriate, the lead exposure registry as established in Public Law 114322 Section 2203b 42
U.S.C. 300j-27; and 5 undertaking of any other review or activities that the Secretary determines to be appropriate.
Annually as determined necessary by the Secretary or as required by Congress, the committee shall submit a report to include: 1 An evaluation of the effectiveness of the Federal programs and services available to individuals and communities exposed to lead; 2 an evaluation of additional lead exposure research needs; 3 an assessment of any effective screening methods or best practices used or developed to prevent or screen for lead exposure; 4 input and recommendations for improved access to effective services relating to health care, education, or nutrition for individuals and communities impacted by lead exposure; and 5 any other recommendations for communities
07SEN1